feed,title,long_url,short_url
Benzinga,RedHill Biopharma Says Its Oral Broad-Acting Antivirals Inhibit Dominant Omicron Sub-Variant BA.5,https://benzinga.com/general/biotech/22/10/29118332/redhill-biopharma-says-its-oral-broad-acting-antivirals-inhibit-dominant-omicron-sub-variant-ba-5,https://bit.ly/3EcQh3Z
